Branched oligonucleotides
US10478503B2 · kind B2 · utility
14Cited by
35References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 30, 2017 |
| Grant date | Nov 19, 2019 |
| Priority date | — |
| Expiry date | Jan 30, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are branched oligonucleotides exhibiting efficient and specific tissue distribution, cellular uptake, minimum immune response and off-target effects, without formulation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.